PL2526951T3 - Ramno-polisacharyd z kompleksu klonalnego 17 Enterococcus faecium i jego zastosowania - Google Patents

Ramno-polisacharyd z kompleksu klonalnego 17 Enterococcus faecium i jego zastosowania

Info

Publication number
PL2526951T3
PL2526951T3 PL11004387T PL11004387T PL2526951T3 PL 2526951 T3 PL2526951 T3 PL 2526951T3 PL 11004387 T PL11004387 T PL 11004387T PL 11004387 T PL11004387 T PL 11004387T PL 2526951 T3 PL2526951 T3 PL 2526951T3
Authority
PL
Poland
Prior art keywords
rhamno
polysaccharide
enterococcus faecium
clonal complex
faecium clonal
Prior art date
Application number
PL11004387T
Other languages
English (en)
Inventor
Johannes Hübner
Christian Theilacker
Zbigniew Kaczyński
Otto Holst
Original Assignee
Univ Freiburg
Forschungszentrum Borstel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Freiburg, Forschungszentrum Borstel filed Critical Univ Freiburg
Publication of PL2526951T3 publication Critical patent/PL2526951T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4233—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-bacterial Ig

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
PL11004387T 2011-05-27 2011-05-27 Ramno-polisacharyd z kompleksu klonalnego 17 Enterococcus faecium i jego zastosowania PL2526951T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP11004387.4A EP2526951B1 (en) 2011-05-27 2011-05-27 Rhamno-polysaccharide from Enterococcus faecium clonal complex 17 and uses thereof

Publications (1)

Publication Number Publication Date
PL2526951T3 true PL2526951T3 (pl) 2016-04-29

Family

ID=44801267

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11004387T PL2526951T3 (pl) 2011-05-27 2011-05-27 Ramno-polisacharyd z kompleksu klonalnego 17 Enterococcus faecium i jego zastosowania

Country Status (9)

Country Link
US (1) US9255157B2 (pl)
EP (1) EP2526951B1 (pl)
JP (1) JP6230991B2 (pl)
CA (1) CA2837411A1 (pl)
DK (1) DK2526951T3 (pl)
ES (1) ES2556951T3 (pl)
HK (1) HK1173393A1 (pl)
PL (1) PL2526951T3 (pl)
WO (1) WO2012163833A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2018328038B2 (en) * 2017-09-07 2024-03-07 Merck Sharp & Dohme Llc Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates
KR102636571B1 (ko) * 2018-01-31 2024-02-15 누트리 컴퍼니 리미티드 폐렴구균 감염증의 예방 및/또는 치료제

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5989542A (en) * 1997-08-20 1999-11-23 Brigham And Women's Hospital, Inc. Capsular polysaccharides from enterococci
US6756361B1 (en) * 1997-10-14 2004-06-29 Nabi Enterococcus antigens and vaccines

Also Published As

Publication number Publication date
CA2837411A1 (en) 2012-12-06
JP2014517866A (ja) 2014-07-24
EP2526951B1 (en) 2015-09-30
JP6230991B2 (ja) 2017-11-15
WO2012163833A1 (en) 2012-12-06
US20140161792A1 (en) 2014-06-12
US9255157B2 (en) 2016-02-09
DK2526951T3 (en) 2016-01-04
HK1173393A1 (en) 2013-05-16
ES2556951T3 (es) 2016-01-21
EP2526951A1 (en) 2012-11-28

Similar Documents

Publication Publication Date Title
IL248036B (en) Medicine bracelets - binding and their use
HK1195793A1 (zh) 結合藥物組合物及其用途
SG10201605278PA (en) Anti-folate receptor alpha antibodies and uses thereof
EP2740741A4 (en) PEPTIDE OBTAINED FROM THE WNT FAMILY AND USES THEREOF
EP2742112A4 (en) CARBAZOLOCARBAZOL-BIS (DICARBOXIMIDES) AND THEIR USE AS SEMICONDUCTORS
IL229844B (en) Anti-psgl-1 antibodies and their use
EP2756838A4 (en) SHAMPOO COMPOSITION
EP2738255A4 (en) PEPTIDE FROM ERAP1 AND ITS USE
HK1191034A1 (en) N-carboxyalkyl-auristatins and use thereof n-
HK1182600A1 (zh) 拉鍊
GB201113770D0 (en) Novel compositions and uses thereof
EP2708532A4 (en) 4-AMINOQUINAZOLINE DERIVATIVES AND USES THEREOF
EP2578107A4 (en) ZIP CLOSURE
IL231082A (en) Pyrimido compounds - pyridazinone and their use
EP2718283A4 (en) INDAZOLE AND PYRROLOPYRIDINE DERIVATIVE AND PHARMACEUTICAL USE THEREOF
EP2604138A4 (en) ZIPPER
EP2637697A4 (en) MODIFIED IMMUNOMODULATING PARTICLES
GB201111630D0 (en) Novel compounds and their use
EP2775831A4 (en) PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
EP2768797A4 (en) NEW MODIFIED CLASSICS AND ITS USES
EP2716359A4 (en) COMPLEX AND USES THEREOF
EP2703344A4 (en) NEW CONTRACTOR AND ITS USE
EP2710063A4 (en) PLASTIFIERS FOR RESIN COMPOSITIONS AND RESIN COMPOSITIONS CONTAINING SAME
PL2667710T3 (pl) Kompozycja owadobójcza i związane z nią sposoby
EP2666482A4 (en) PARTICLE COMPOSITION AND PHARMACEUTICAL COMPOSITION WITH PARTICLE COMPOSITION